Herbas VPB

Print
EN | LT
LT - USE OF EDARAVONE IN PREPARING DRUG FOR PREVENTING AND TREATING CEREBRAL AMYLOID ANGIOPATHY (CAA)
EN - USE OF EDARAVONE IN PREPARING DRUG FOR PREVENTING AND TREATING CEREBRAL AMYLOID ANGIOPATHY (CAA)

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/4152 (2006.01)
A61K 9/08 (2006.01)
A61K 9/20 (2006.01)
A61K 9/48 (2006.01)
A61P 25/00 (2006.01)
A61K 45/06 (2006.01)
A61P 25/28 (2006.01)
A61K 39/395 (2006.01)
European patent
(11) Number of the document 3216447
(13) Kind of document T
(96) European patent application number 15857765.0
Date of filing the European patent application 2015-11-05
(97) Date of publication of the European application 2017-09-13
(45) Date of publication and mention of the grant of the patent 2021-06-02
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/CN2015/093837
Date 2015-11-05
PCT application publication
(87) Number WO 2016/070817
Date 2016-05-12
Priority applications
(30) Number Date Country code
201410618300 2014-11-05 CN
Inventors
(72)
WANG, Yanjiang , CN
JIAO, Shusheng , CN
YAO, Xiuqing , CN
ZHOU, Xinfu , AU
Grantee
(73) The Third Affiliated Hospital Third Military Medical University, PLA , 10 Changjiang Branch Road Daping, Yuzhong District, Chongqing 400042, CN
Title
(54) USE OF EDARAVONE IN PREPARING DRUG FOR PREVENTING AND TREATING CEREBRAL AMYLOID ANGIOPATHY (CAA)
  USE OF EDARAVONE IN PREPARING DRUG FOR PREVENTING AND TREATING CEREBRAL AMYLOID ANGIOPATHY (CAA)